Disc Medicine
Disc Medicine is seeking a strategic Senior Director of Toxicology to lead nonclinical safety assessments and drive toxicology strategy across its portfolio. Reporting to the Vice President, Head of Toxicology, the role involves designing and interpreting GLP studies, integrating pharmacokinetic data, and guiding cross‑functional teams from early discovery through regulatory submissions.
Disc Medicine is a clinical‑stage biopharmaceutical company focused on developing first‑in‑class therapeutics for hematologic disorders. The company harnesses breakthrough science to translate discoveries into medicines designed to disrupt the current standard of care and improve outcomes for patients and families. Its pipeline includes programs in clinical development and the company works closely with patients, healthcare professionals, investors and partners to advance those therapies. Headquartered in Watertown, Massachusetts, Disc Medicine provides medical, investor and partnership contact channels via its website.
First Light Asset Management LLC Acquires New Holdings in Disc Medicine, Inc. $IRON
15 hours ago
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
2 days ago
FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher
1 month ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Disc Medicine.
23% above the average for this role
US FDA declines to approve Disc Medicine's rare disease drug
1 month ago
Director, Toxicology
Praxis Precision Medicines, Inc.
Director/Senior Director, Nonclinical Safety
Nimbus Therapeutics
Associate Director, Toxicology, Nonclinical Development (Program Toxicologist)
8a7882525b6027b0015b692822e001ab
Vice President of Nonclinical Drug Safety and Toxicology
Remix Therapeutics
Senior Principal Scientist / Associate Director, Toxicology
Orum Therapeutics
Senior Director, Toxicology
Amylyx Pharmaceuticals